Compare AbCellera Biologics Inc (ABCL) vs LTC Properties Inc (LTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs LTC Properties Inc — how do they compare? AbCellera Biologics Inc trades at $9.13 (market cap $2.99B), while LTC Properties Inc trades at $38.12 (market cap $2.05B). The key difference: AbCellera Biologics Inc is the larger of the two by market cap, and LTC Properties Inc pays a 5.98% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | LTC | |
|---|---|---|
Market Cap | $2.99B | $2.05B |
Sector | Health | Real Estate |
52-Week High | $9.76 | $42.81 |
52-Week Low | $2.78 | $33.98 |
Enterprise Value | $2.58B | $2.79B |
Dividend Yield | — | 5.98% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About LTC Properties Inc
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →
